Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Maternal mortality highlighted Americas' need for wider healthcare cover

This article was originally published in Clinica

Executive Summary

The Pan American Health Organization (PAHO) is calling for national health policies to better address the need to expand medical coverage among indigenous communities, particularly in light of the high rates of infant and maternal mortality among these. The latest edition of its bulletin on indigenous health - Healing our Spirit Worldwide - notes that national averages can mask significant regional variations in these rates. In Bolivia, for example, maternal mortality stands nationally at 390 per 100,000 live births, but in the department of Potosi, home to a large indigenous population, the rate is 496. Similarly, the Honduran departments of Colon, Copan, Intibuca, Lempira and La Paz have maternal mortality rates ranging from 190 to 255 per 100,000 live births, compared with a national average of 147. In Guatemala, maternal mortality is 83% higher among indigenous women than the national rate.

You may also be interested in...



Changes To EU Pharma Reform: More Questions Than Answers?

In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.

Probiotics And Cold Remedies Boost Recordati In 2023

Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.

Falling Sales Force New Priorities At Roche

The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT059025

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel